Suchen Sie nach Informationen zu Masimo-Unternehmenszentrale? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
Masimo (NASDAQ: MASI) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors.
https://www.masimo.com/company/masimo/about/
Masimo is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. We believe that Masimo SET® helps clinicians monitor in excess of approximately 100 million patients in healthcare settings around the world, and is the primary pulse oximetry technology …
https://www.masimo.com/healthcare/
Hospital Automation. Automating certain aspects of healthcare can give skilled clinicians the time and tools to consistently deliver optimal care at a lower cost. Masimo SET ® Advancing Patient Safety. The accuracy and reliability of Masimo SET ® pulse oximetry has been studied in challenging conditions. Live Webinar.
https://www.masimo.com/company/contact/contact-us/
Masimo International Sàrl. Route de Pierre-à-Bot 97. 2000 Neuchâtel Switzerland. Tel: +41 32 720 11 66. Fax: +41 32 720 11 65. Email: [email protected]. Email: [email protected]. Email: [email protected]. If your company is interested in licensing Masimo SET ® or Masimo rainbow SET™ technologies, please contact.
https://www.masimo.com/monitoring-solutions/
Masimo offers multiple advanced noninvasive and continuous monitoring technologies, available on a single integrated platform and on select third-party multi-parameter monitors. Masimo's breakthrough Signal Extraction Technology® (SET®) overcomes the limitations of conventional pulse oximetry with the ability to measure through motion and low ...
https://investor.masimo.com/financials/annual-reports/default.aspx
© Masimo. All Rights Reserved. Powered By Q4 Inc. 5.74.0.1 (opens in new window) 5.74.0.1 (opens in new window)
https://agile.masimo.com/Agile/default/login-cms.jsp
https://investor.masimo.com/governance/executive-management/default.aspx
Bilal Muhsin. Chief Operating Officer. Micah Young. Executive Vice President & Chief Financial Officer. Tom McClenahan. Executive Vice President, General Counsel. Tao Levy. Executive Vice President, Business Development. Kevin Duffy.
https://investor.masimo.com/company-profile/default.aspx
Company Profile. We are a global medical technology company that develops, manufactures, and markets a variety of noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications. We were incorporated in California in May 1989 and ...
https://investor.masimo.com/news/news-details/2022/Masimo-Reports-Fourth-Quarter-and-Full-Year-2021-Financial-Results-and-Announces-Agreement-to-Acquire-Sound-United/default.aspx
Fourth Quarter 2021 Highlights: Product revenue increased 11.0% to $327.6 million, GAAP net income per diluted share was $1.18; and Non-GAAP net income per diluted share was $1.21. Full-Year 2021 Highlights: Product revenue increased 8.3% to $1,239.2 million, GAAP net income per diluted share was $3.98; and Non-GAAP net income per diluted share was $3.99. …
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Masimo-Unternehmenszentrale gefunden haben.
